Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
The Journal of Urology
|
May 15, 2007
Finasteride decreases the risk of prostatic intraepithelial neoplasia
Ian M Thompson, M Scott Lucia, Mary W Redman, et al.
Cancer
|
March 22, 2012
Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer
Yingwei Qi, Katie L Allen Ziegler, Shauna L Hillman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 10, 2014
Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials
Primo N Lara, James Moon, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay
Primo N Lara, James Moon, Paul J Hesketh, et al.
JCO Clinical Cancer Informatics
|
April 21, 2023
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)
Shing M Lee, Weijia Fan, Aijin Wang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2024
Pragmaticism in Cancer Clinical Trials
Kamya Sankar, Mary W Redman, Konstantin H Dragnev, et al.
Blood Advances
|
July 25, 2019
Challenges and approaches to implementing master/basket trials in oncology
Amy Burd, Richard L Schilsky, John C Byrd, et al.
Clinical Lung Cancer
|
February 19, 2013
Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma
Derick H M Lau, James Moon, Angela M Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2008
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003
Philip C Mack, Mary W Redman, Kari Chansky, et al.
Clinical Lung Cancer
|
December 28, 2020
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)
Hossein Borghaei, Mary W Redman, Karen Kelly, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
The Journal of Urology
|
May 15, 2007
Finasteride decreases the risk of prostatic intraepithelial neoplasia
Ian M Thompson, M Scott Lucia, Mary W Redman, et al.
Cancer
|
March 22, 2012
Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer
Yingwei Qi, Katie L Allen Ziegler, Shauna L Hillman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 10, 2014
Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials
Primo N Lara, James Moon, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay
Primo N Lara, James Moon, Paul J Hesketh, et al.
JCO Clinical Cancer Informatics
|
April 21, 2023
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)
Shing M Lee, Weijia Fan, Aijin Wang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2024
Pragmaticism in Cancer Clinical Trials
Kamya Sankar, Mary W Redman, Konstantin H Dragnev, et al.
Blood Advances
|
July 25, 2019
Challenges and approaches to implementing master/basket trials in oncology
Amy Burd, Richard L Schilsky, John C Byrd, et al.
Clinical Lung Cancer
|
February 19, 2013
Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma
Derick H M Lau, James Moon, Angela M Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2008
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003
Philip C Mack, Mary W Redman, Kari Chansky, et al.
Clinical Lung Cancer
|
December 28, 2020
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)
Hossein Borghaei, Mary W Redman, Karen Kelly, et al.
Page
of 9